🇺🇸 FDA
Patent

US 9802904

Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 9802904 (Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00